- Trials with a EudraCT protocol (161)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
161 result(s) found for: Heart valve.
Displaying page 1 of 9.
EudraCT Number: 2009-017625-20 | Sponsor Protocol Number: NAROSYD | Start Date*: 2010-06-22 | ||||||||||||||||
Sponsor Name:Pawel Florkiewicz | ||||||||||||||||||
Full Title: Continuous ropivacaine infusion in treatment of postoperative pain in cardiac surgery. | ||||||||||||||||||
Medical condition: Research is to verify whether continuous infusion of ropivacaine reduces post-operative analgesic requirement after cardiac surgery. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002650-38 | Sponsor Protocol Number: Pre65 | Start Date*: 2008-07-01 | |||||||||||||||||||||
Sponsor Name:Organisation name was not entered | |||||||||||||||||||||||
Full Title: Vähentääkö pregabaliini opioidikipulääkityksen tarvetta ja kroonisen kivun esiintyvyyttä alle 65-vuotiailla potilailla sydänleikkauksen jälkeen? | |||||||||||||||||||||||
Medical condition: Tutkimukseen otetaan potilaan suostumuksella alle 65-vuotiaita avosydänleikkauk-seen joko koronaariohitus- tai sydämen läppärekonstruktioon tulevia potilaita, jotka leikatataan perfuusioleikkauksena. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FI (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002898-26 | Sponsor Protocol Number: CHBX2020/49 | Start Date*: 2022-07-01 |
Sponsor Name:CHU DE BORDEAUX | ||
Full Title: Contribution of PET/CT with Gallium 68 citrate (68Ga-PET/CT) for the diagnosis of prosthetic valve infective endocarditis | ||
Medical condition: Prosthetic valve infective endocarditis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000077-57 | Sponsor Protocol Number: 2021-THORANE-Pharma-001 | Start Date*: 2022-06-25 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Rigshospitalet | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Methadone versus fentanil and oxycodone for post-operative pain reduction in patients undergoing coronary artery bypass grafting and/or valve surgery – a placebo-controlled, double-blind, randomiz... | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: We investigate the efficacy of methadonehydrochloride for reducing optoperative opioid requirements, pain scores and improving quality of recovery in patients undergoing heart surgery (i.e. corona... | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Trial now transitioned) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000111-26 | Sponsor Protocol Number: MEIN/10/Ran-Did/002 | Start Date*: 2011-07-01 | |||||||||||
Sponsor Name:A. MENARINI PHARMA U.K., | |||||||||||||
Full Title: Effect of late sodium current inhibition on MRI measured diastolic dysfunction and myocardial perfusion reserve in aortic stenosis - a proof of concept study. | |||||||||||||
Medical condition: Aortic stenosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001752-43 | Sponsor Protocol Number: SEVO-AIFA-FARM6H73Z9 | Start Date*: 2008-07-17 | |||||||||||
Sponsor Name:OSPEDALE S. RAFFAELE | |||||||||||||
Full Title: CARDIAC PROTECTION WITH SEVOFLURANE IN PATIENTS WITH HIGH RISK UNDERGOING HEART SURGERY. RANDOMIZED, CONTROLLED STUDY. | |||||||||||||
Medical condition: adult patients affected by cardiac valve and heart patology undergoing elective surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005586-40 | Sponsor Protocol Number: NL79407.091.21 | Start Date*: 2022-05-30 |
Sponsor Name:Radboudumc | ||
Full Title: Colchicine and Inflammation in Aortic Stenosis | ||
Medical condition: Aortic stenosis (AS) is the most common valvular heart disease in the developed world. The prevalence of aortic sclerosis in the general population is estimated to be 25% at the age of 65 years and... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003973-42 | Sponsor Protocol Number: 2007.490/33 | Start Date*: 2008-09-04 | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: PC Pharma CVA : PostConditionnement pharmacologique au cours de la Chirurgie Valvulaire Aortique | |||||||||||||
Medical condition: chirurgie valvulaire aortique | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003927-13 | Sponsor Protocol Number: REAC-TAVI2 | Start Date*: 2021-10-15 | |||||||||||||||||||||
Sponsor Name:Fundación Biomédica Galicia Sur | |||||||||||||||||||||||
Full Title: Single antiplatelet therapy with Ticagrelor vs Aspirin after Transcatheter Aortic Valve Implantation: multicenter randomized clinical trial. REAC TAVI 2 | |||||||||||||||||||||||
Medical condition: Symptomatic severe aortic stenosis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004178-23 | Sponsor Protocol Number: T39/2021 | Start Date*: 2021-04-14 | ||||||||||||||||
Sponsor Name:Turku University Hospital | ||||||||||||||||||
Full Title: Ultrasound Guided Repeated Bilateral Transversus Thoracis Muscle Plane Block (TTP) via catheter and postoperative pain in Cardiac Surgery | ||||||||||||||||||
Medical condition: cardiac disease necessitating surgery with sternotomy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-004295-28 | Sponsor Protocol Number: STER-AMVR-01 | Start Date*: 2014-11-14 | |||||||||||
Sponsor Name:Oulu University Hospital, Department of Anaesthesia | |||||||||||||
Full Title: Postoperative pain management after heart valve surgery using parasternal block and PCA Oxycodone | |||||||||||||
Medical condition: Mitral or aortic valve disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003391-39 | Sponsor Protocol Number: 9026 | Start Date*: 2012-10-26 | |||||||||||
Sponsor Name:University Hospital of Montpellier | |||||||||||||
Full Title: Ballon aortic valvuloplasty performed without heparin to decrease vascular and bleeding complications of the procedure | |||||||||||||
Medical condition: Aortic stenosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000017-20 | Sponsor Protocol Number: ASS-Metamizol-DDI | Start Date*: 2018-07-17 |
Sponsor Name:Universitäts-Herzzentrum Freiburg • Bad Krozingen | ||
Full Title: Antiplatelet effect of acetylsalicylic acid in patients after cardiac surgery: Impact of dipyrone (metamizole) | ||
Medical condition: Antithrombotic therapy after surgical replacement of stenotic heart valve by a bioprosthesis or mitral valve repair | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000518-34 | Sponsor Protocol Number: 0107 | Start Date*: 2011-10-25 | |||||||||||
Sponsor Name:Rikshospitalet | |||||||||||||
Full Title: Effect of beta blockade on left ventricular remodeling and function in aortic regurgitation | |||||||||||||
Medical condition: The aim of the present study is therefore to assess the effect of a 6 month treatment with beta-blocker on left ventricular remodeling and function in patients with asymptomatic moderate to severe ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001675-32 | Sponsor Protocol Number: ARTE | Start Date*: 2014-10-20 | |||||||||||
Sponsor Name:IUCPQ | |||||||||||||
Full Title: Aspirin versus Aspirin + ClopidogRel as Antithrombotic Treatment Following Transcatheter Aortic Valve Implantation with the Edwards Valve. A Randomized Study (the ARTE trial). | |||||||||||||
Medical condition: Incidence of death, MI, ischemic stroke/Transient ischemic attack (TIA) or life threatening/major bleeding at 3-month follow-up. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002015-17 | Sponsor Protocol Number: 2016-002015-17 | Start Date*: 2017-03-10 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Low-flow Low-gradient Aortic Stenosis – Diagnostic Usefullness of Ivabradine | |||||||||||||
Medical condition: Aortic valve stenosis with reduced ejection fraction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002799-18 | Sponsor Protocol Number: ICICOR-2017-01 | Start Date*: 2017-12-27 | |||||||||||
Sponsor Name:José Alberto San Román Calvar | |||||||||||||
Full Title: Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI) | |||||||||||||
Medical condition: Severe aortic stenosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004457-23 | Sponsor Protocol Number: 29BRC21.0255 | Start Date*: 2022-01-24 | ||||||||||||||||
Sponsor Name:CHU de Brest | ||||||||||||||||||
Full Title: Impact of local tissue inflammation on intramyocardial conduction pathways post percutaneous valve : evaluation by positron emission tomography | ||||||||||||||||||
Medical condition: Aortic stenosis TAVI Cardiac conduction disorders Pacemaker | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001975-30 | Sponsor Protocol Number: BAY59-7939/17938 | Start Date*: 2016-01-12 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: Global multicenter, open-label, randomized, event-driven, active-controlled study comparing a rivAroxaban-based antithrombotic strategy to an antipLatelet-based strategy after transcatheter aortIc ... | |||||||||||||
Medical condition: Patients with severe aortic stenosis that require Transcatheter aortic valve replacement are at risk of thrombus formation. Rivaroxaban (oral-anticoagulant) may reduce this risk, without increasing... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) ES (Prematurely Ended) BE (Prematurely Ended) NO (Prematurely Ended) AT (Prematurely Ended) DK (Prematurely Ended) SE (Prematurely Ended) NL (Prematurely Ended) GB (Prematurely Ended) FR (Prematurely Ended) CZ (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004653-24 | Sponsor Protocol Number: ARBAS041218 | Start Date*: 2020-06-15 | |||||||||||
Sponsor Name:Odense Universitets Hospital | |||||||||||||
Full Title: Impact of an Angiotensin Receptor Blocker in Aortic Stenosis – A Randomized Controlled Trial | |||||||||||||
Medical condition: Aortic valve stenosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
